MedPath

Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia

Conditions
Chronic Myeloid Leukemia
Registration Number
NCT00302016
Lead Sponsor
Novartis Pharmaceuticals
Brief Summary

This study will further evaluate if AMN107 is safe in adults with chronic myeloid leukemia who are resistant or intolerant to imatinib and to provide patients access to this new drug until the drug becomes commercially available.

Detailed Description

Not available

Recruitment & Eligibility

Status
NO_LONGER_AVAILABLE
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
EXPANDED_ACCESS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (59)

Rush University Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Chicago, Illinois, United States

Stroger Cook County Hospital

๐Ÿ‡บ๐Ÿ‡ธ

Chicago, Illinois, United States

Swedish Cancer Institute

๐Ÿ‡บ๐Ÿ‡ธ

Seattle, Washington, United States

Advanced Medical Specialties

๐Ÿ‡บ๐Ÿ‡ธ

Miami, Florida, United States

Cancer Center of Kansas

๐Ÿ‡บ๐Ÿ‡ธ

Wichita, Kansas, United States

University of Rochester Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Rochester, New York, United States

Arizona Cancer Center

๐Ÿ‡บ๐Ÿ‡ธ

Tucson, Arizona, United States

St. Francis Hospital & Health Centers

๐Ÿ‡บ๐Ÿ‡ธ

Beech Grove, Indiana, United States

Osler Medical Inc./Osler Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Melbourne, Florida, United States

Antelope Valley Cancer Center

๐Ÿ‡บ๐Ÿ‡ธ

Lancaster, California, United States

University of Chicago Hospital

๐Ÿ‡บ๐Ÿ‡ธ

Chicago, Illinois, United States

Washington Cancer Institute

๐Ÿ‡บ๐Ÿ‡ธ

Washington, District of Columbia, United States

University of South Alabama Cancer Research Institute

๐Ÿ‡บ๐Ÿ‡ธ

Mobile, Alabama, United States

Integrated Community

๐Ÿ‡บ๐Ÿ‡ธ

Orange Park, Florida, United States

Stanford University

๐Ÿ‡บ๐Ÿ‡ธ

Palo Alto, California, United States

Hematology Oncology Assoc.

๐Ÿ‡บ๐Ÿ‡ธ

Pensacola, Florida, United States

Emory University Cancer Institute

๐Ÿ‡บ๐Ÿ‡ธ

Atlanta, Georgia, United States

Wake Forest University

๐Ÿ‡บ๐Ÿ‡ธ

Winston Salem, North Carolina, United States

Wayne State University

๐Ÿ‡บ๐Ÿ‡ธ

Detroit, Michigan, United States

University of Colorado

๐Ÿ‡บ๐Ÿ‡ธ

Aurora, Colorado, United States

Rocky Mountain Cancer Center

๐Ÿ‡บ๐Ÿ‡ธ

Denver, Colorado, United States

Mayo Clinic Hospital

๐Ÿ‡บ๐Ÿ‡ธ

Rochester, Minnesota, United States

Nebraska Methodist Cancer Center

๐Ÿ‡บ๐Ÿ‡ธ

Omaha, Nebraska, United States

Duke University

๐Ÿ‡บ๐Ÿ‡ธ

Durham, North Carolina, United States

Vanderbilt University Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Nashville, Tennessee, United States

Utah Cancer Specialists

๐Ÿ‡บ๐Ÿ‡ธ

Salt Lake City, Utah, United States

Medical College of Georgia

๐Ÿ‡บ๐Ÿ‡ธ

Augusta, Georgia, United States

Georgetown University Medical Center-Lombardi Cancer Center

๐Ÿ‡บ๐Ÿ‡ธ

Washington, District of Columbia, United States

University of Illinois at Chicago

๐Ÿ‡บ๐Ÿ‡ธ

Chicago, Illinois, United States

Loyola University Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Maywood, Illinois, United States

St. Agnes Hospital

๐Ÿ‡บ๐Ÿ‡ธ

Baltimore, Maryland, United States

St. John Hospital and Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Grosse Pointe, Michigan, United States

LSU Health Sciences Center

๐Ÿ‡บ๐Ÿ‡ธ

Shreveport, Louisiana, United States

Southeast Nebraska Cancer Center

๐Ÿ‡บ๐Ÿ‡ธ

Lincoln, Nebraska, United States

Nevada Cancer Institute

๐Ÿ‡บ๐Ÿ‡ธ

Las Vegas, Nevada, United States

Cancer Institute of New Mexico

๐Ÿ‡บ๐Ÿ‡ธ

Santa Fe, New Mexico, United States

University of New Mexico Health Sciences Center

๐Ÿ‡บ๐Ÿ‡ธ

Albuquerque, New Mexico, United States

Hackensack University Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Hackensack, New Jersey, United States

Winthrop Hematology/Oncology

๐Ÿ‡บ๐Ÿ‡ธ

Mineola, New York, United States

Memorial Sloan Kettering Cancer Center

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Weill Cornell Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Mount Sinai Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Oregon Health Sciences University

๐Ÿ‡บ๐Ÿ‡ธ

Portland, Oregon, United States

Western Pennsylvania Cancer Institute

๐Ÿ‡บ๐Ÿ‡ธ

Pittsburgh, Pennsylvania, United States

Charleston Hematology Oncology

๐Ÿ‡บ๐Ÿ‡ธ

Charleston, South Carolina, United States

Three Medical Park

๐Ÿ‡บ๐Ÿ‡ธ

Columbia, South Carolina, United States

Cancer Center of the Carolinas

๐Ÿ‡บ๐Ÿ‡ธ

Greenville, South Carolina, United States

The Jones Clinic

๐Ÿ‡บ๐Ÿ‡ธ

Germantown, Tennessee, United States

MUSC Hollings Cancer Center

๐Ÿ‡บ๐Ÿ‡ธ

Charleston, South Carolina, United States

UT Southwestern Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Dallas, Texas, United States

Novartis Investigative Site

๐Ÿ‡ฌ๐Ÿ‡ง

Nottingham, United Kingdom

University of Iowa Hospitals & Clinics

๐Ÿ‡บ๐Ÿ‡ธ

Iowa City, Iowa, United States

Louisville Oncology Research

๐Ÿ‡บ๐Ÿ‡ธ

Louisville, Kentucky, United States

Roswell Park Cancer Institute

๐Ÿ‡บ๐Ÿ‡ธ

Buffalo, New York, United States

Cancer Care Associates

๐Ÿ‡บ๐Ÿ‡ธ

Tulsa, Oklahoma, United States

Florida Hospital Cancer Institute

๐Ÿ‡บ๐Ÿ‡ธ

Orlando, Florida, United States

MD Anderson Cancer Center

๐Ÿ‡บ๐Ÿ‡ธ

Orlando, Florida, United States

University of Michigan

๐Ÿ‡บ๐Ÿ‡ธ

Ann Arbor, Michigan, United States

City of Hope National Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Duarte, California, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath